}

FDA warns compounders about glutathione

02/05/2019

FDA is warning compounders not to use glutathione-L-reduced powder distributed by Letco Medical, to compound sterile injectable drugs for patients. Based on reported adverse events, the agency has concerns about potential endotoxins in the product.

<< return to Advocacy Updates